Antifosfolipidsyndrom og graviditet

Karen Schreiber; Jacob Alexander Lykke; Jens Langhoff-Roos; Henriette Svarre Nielsen; Søren Jacobsen

Antifosfolipidsyndrom og graviditet

Karen Schreiber, Jacob Alexander Lykke, Jens Langhoff-Roos, Henriette Svarre Nielsen, Søren Jacobsen

Institut for Klinisk Medicin

1 Citationer (Scopus)

Abstract

Antiphospholipid syndrome (APS) is the association of antiphospholipid antibodies with thromboses and/or obstetric morbidity. Obstetric morbidity includes recurrent first trimester loss, stillbirth, intrauterine death, preeclam-psia, premature birth and fetal growth restriction. Although current treatment regimens including aspirin and low-molecular weight heparin have improved pregnancy outcomes, 30% of affected women have pregnancy complica-tions. Women with APS are therefore high-risk pregnancies who should be monitored in specialist centres according to international standards.

Bidragets oversatte titel	Antiphospholipid syndrome and pregnancy
Originalsprog	Dansk
Artikelnummer	V09150730
Tidsskrift	Ugeskrift for Laeger
Vol/bind	178
Udgave nummer	12
Sider (fra-til)	2-5
ISSN	0041-5782
Status	Udgivet - jan. 2016

Citationsformater

@article{f3a75f0b776b48028a7d5caf465ab8a6,

title = "Antifosfolipidsyndrom og graviditet",

abstract = "Antiphospholipid syndrome (APS) is the association of antiphospholipid antibodies with thromboses and/or obstetric morbidity. Obstetric morbidity includes recurrent first trimester loss, stillbirth, intrauterine death, preeclam-psia, premature birth and fetal growth restriction. Although current treatment regimens including aspirin and low-molecular weight heparin have improved pregnancy outcomes, 30% of affected women have pregnancy complica-tions. Women with APS are therefore high-risk pregnancies who should be monitored in specialist centres according to international standards.",

keywords = "English Abstract, Journal Article",

author = "Karen Schreiber and Lykke, {Jacob Alexander} and Jens Langhoff-Roos and Nielsen, {Henriette Svarre} and S{\o}ren Jacobsen",

year = "2016",

month = jan,

language = "Dansk",

volume = "178",

pages = "2--5",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "12",

}

TY - JOUR

T1 - Antifosfolipidsyndrom og graviditet

AU - Schreiber, Karen

AU - Lykke, Jacob Alexander

AU - Langhoff-Roos, Jens

AU - Nielsen, Henriette Svarre

AU - Jacobsen, Søren

PY - 2016/1

Y1 - 2016/1

N2 - Antiphospholipid syndrome (APS) is the association of antiphospholipid antibodies with thromboses and/or obstetric morbidity. Obstetric morbidity includes recurrent first trimester loss, stillbirth, intrauterine death, preeclam-psia, premature birth and fetal growth restriction. Although current treatment regimens including aspirin and low-molecular weight heparin have improved pregnancy outcomes, 30% of affected women have pregnancy complica-tions. Women with APS are therefore high-risk pregnancies who should be monitored in specialist centres according to international standards.

AB - Antiphospholipid syndrome (APS) is the association of antiphospholipid antibodies with thromboses and/or obstetric morbidity. Obstetric morbidity includes recurrent first trimester loss, stillbirth, intrauterine death, preeclam-psia, premature birth and fetal growth restriction. Although current treatment regimens including aspirin and low-molecular weight heparin have improved pregnancy outcomes, 30% of affected women have pregnancy complica-tions. Women with APS are therefore high-risk pregnancies who should be monitored in specialist centres according to international standards.

KW - English Abstract

KW - Journal Article

M3 - Tidsskriftartikel

C2 - 26815583

SN - 0041-5782

VL - 178

SP - 2

EP - 5

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 12

M1 - V09150730

ER -

Antifosfolipidsyndrom og graviditet

Abstract

Fingeraftryk

Citationsformater